Pharmaceutical Industry Fellowship Programs

St. John’s University/American Regent, Inc. Pharmaceutical Industry Fellowship—Medical Affairs

Nicole Conciardo, Pharm.D.

Nicole Conciardo, Pharm.D., is the 2025–27 St. John’s University/American Regent fellow in Medical Affairs.  

Dr. Conciardo earned her Doctor of Pharmacy degree from St. John Fisher University in Rochester, NY. During pharmacy school, she completed a highly selective medical affairs rotation in oncology focused on TIL cell therapy—one of only two students chosen for the opportunity. Her passion for industry led her to advocate for, and complete, a second back-to-back rotation in medical information—making her the first student from her program to do so. These experiences solidified her interest in medical affairs and helped shape her professional trajectory.

Beyond rotations, Dr. Conciardo founded the Student Pharmacy Research and Industry Interest Group (SPRIIG) at St. John Fisher. Through SPRIIG, she created a space for students to explore careers in industry, organized guest speaker events with professionals across pharma, and mentored peers who were navigating early interest in nontraditional pharmacy pathways.

Following graduation, Dr. Conciardo worked as a staff pharmacist at CVS, where she gained firsthand experience in patient care, medication safety, and high-volume pharmacy operations. Her time in retail strengthened her ability to make clinical decisions quickly, communicate with diverse patient populations, and collaborate across interdisciplinary teams.

Originally from upstate New York, Dr. Conciardo enjoys staying active with yoga, taking long walks with her dog, and escaping to Florida during the winter months. She’s also an avid reader—currently challenging herself to finish a new book each month. Her favorite read so far: Maybe in Another Life by Taylor Jenkins Reid. Dr. Conciardo is excited to continue growing in her industry journey and looks forward to what’s ahead.

Isabella Iacovino, Pharm.D.

Isabella Iacovino, Pharm.D., is the 2026–28 St. John’s University/American Regent fellow in Medical Affairs.

Dr. Iacovino earned her Doctor of Pharmacy degree from the University of Rhode Island in Kingston, RI. During pharmacy school, she completed a comprehensive medical affairs rotation spanning the stroke, cardiorenal, hematology, neurology, and established brands divisions at Bayer. In this role, she contributed to scientific communications, cross-functional collaboration, and the generation of clinical insights through the development and presentation of clinical content. These experiences deepened her understanding of the impact of medical affairs and solidified her interest in pursuing a career within the pharmaceutical industry.

Beyond rotations, Dr. Iacovino was actively involved in numerous pharmacy organizations. She served as a Peer Mentor for the URI College of Pharmacy Class of 2028, providing academic support through individualized study strategies, shared learning tools, and guidance on navigating the curriculum. As part of the university’s “RAMbassador” Program, she served as Lead College of Pharmacy Ambassador and oversaw the College of Pharmacy’s social media presence for the 2024–25 academic year.

Within her professional pharmacy fraternity, Lambda Kappa Sigma, Dr. Iacovino held several leadership positions, including Lead Student Director of the Poison Prevention Program, Historian on the Executive Board, and Social Committee Chair. She was also inducted into Phi Lambda Sigma, the National Pharmacy Leadership Society, recognized for her leadership within the profession.

In addition to her academic and leadership roles, Dr. Iacovino was a student‑athlete on the University of Rhode Island Cheerleading team, representing the university at community and athletic events, and competing nationally at the NCAA Division I level, including UCA College Nationals.

Dr. Iacovino also gained hands-on experience as a Pharmacy Intern at Walgreens for three years, where she strengthened her clinical communication skills, patient counseling abilities, and understanding of medication safety in a high-volume setting.

Originally from New Jersey, Dr. Iacovino enjoys staying active through running and has completed two half-marathons. She helps coach a local high school cheerleading team and enjoys spending time with friends and family. Isabella is thrilled to join the American Regent team and looks forward to the opportunities and growth that the fellowship will bring.

St. John’s University/Pfizer Inc. Pharmaceutical Industry Fellowship—Oncology Global Market Access and Health Economics and Outcomes Research (HEOR)

Janvi Lagdiwala, Pharm.D.

Janvi Lagdiwala, Pharm.D.,is the 2025–27 St. John’s University/ Pfizer Inc. Pharmaceutical Industry Fellow in Oncology Global Market Access and Health Economics and Outcomes Research.

Dr. Lagdiwala earned her Doctor of Pharmacy degree from the Ernest Mario School of Pharmacy at Rutgers University. During her time in pharmacy school, she served as the Vice President of the Academy of Managed Care Pharmacy (AMCP) organization and participated in research focused on transdermal pharmacology.

Dr. Lagdiwala spent three years at Daiichi Sankyo Inc., in both their US Market Access and US Medical Affairs Training and Development teams, working across their oncology portfolio and preparing for launch readiness. These experiences ignited her passion to pursue an opportunity within the oncology space. Following her rotational experiences at Bristol Myers Squibb in Business Insights & Analytics and Horizon BCBSNJ in Managed Care, Dr. Lagdiwala solidified her interest in Market Access and HEOR. She is excited to gain valuable experiences and work alongside a diverse team at Pfizer and St. John’s University, with the goal of improving patient access to new therapies worldwide.

Nelia Rahmany, Pharm.D.

Nelia Rahmany, Pharm.D., M.B.A., is the 2026–28 St. John’s University/Pfizer Inc. Pharmaceutical Industry Fellow in Oncology Global Market Access and Health Economics and Outcomes Research.

Dr. Rahmany earned her Doctor of Pharmacy and Master of Business Administration dual degree from Shenandoah University. During her time in pharmacy school, she held leadership roles within the National Community Oncology Dispensing Association, where she spearheaded donor drives to expand the national registry and led educational initiatives on hematologic cancer risks. She also distinguished herself through robust research initiatives, conducting a pharmacoeconomic analysis on reducing psychiatric recidivism rates and identifying epigenetic biomarkers for stress reduction.

Dr. Rahmany’s passion for oncology and market access was solidified during her clinical track at Johns Hopkins Bayview Medical Center. It was her experience navigating complex reimbursement barriers for high-cost therapies and leveraging health informatics to automate clinical solutions that drove her commitment to the pharmaceutical industry. She is eager to apply her technical expertise in data analytics alongside evidence generation strategies to improve patient access to Pfizer’s oncology portfolio.

St. John’s University/Allergan Aesthetics, an AbbVie Company, Pharmaceutical Industry Fellowship—Clinical Development

Rola Elzein, Pharm.D.

Rola Elzein, Pharm.D., is the 2025–27 St. John’s University/Allergan Aesthetics Fellow in Clinical Development.

Dr. Elzein earned her Doctor of Pharmacy degree from Virginia Commonwealth University School of Pharmacy in Richmond, VA. During her time in pharmacy school, she served as the Internship Director for the Industry Pharmacists Organization (IPhO) from 2024–25, following a prior role as the Fellowship Catalog Intern in the Fall of 2023.

Dr. Elzein gained valuable industry experience through internships in both the public and private sectors. She worked as a Market Access Intern at Cencora, where she supported access strategy and value demonstration initiatives. She also completed a Clinical Pharmacology internship at the US Food and Drug Administration, where she conducted research on clinical trial designs for insulin biosimilar products.

Dr. Elzein is excited to be joining the Plastics/Regenerative Medicine and Filler teams at Allergan Aesthetics. She looks forward to learning from cross-functional partners, advancing her understanding of clinical development, and deepening her passion for aesthetics while helping translate scientific innovation into impactful therapies for patients that will empower confidence.

Originally from Suffolk, VA, Dr. Elzein holds an undergraduate degree in biology from the College of William and Mary and Old Dominion University. Outside of her professional pursuits, she enjoys traveling, trying new food spots, and watching movies.

Colleen Oshodi, Pharm.D.

Colleen Oshodi, Pharm.D., is the St. John’s University/Allergan Aesthetics, an AbbVie Company, Clinical Development Fellow for the 2026–28 fellowship term.

Dr. Oshodi earned her Doctor of Pharmacy degree from Mercer University College of Pharmacy in Atlanta, GA, with a strong interest in clinical care, research, and drug development. During her training, she gained hands-on experience in clinical research, dermatology, and aesthetic medicine, where she contributed to the conduct and coordination of research studies. She developed an appreciation for the role of clinical development in bringing therapies from concept to patient care.

In addition to her research background, Dr. Oshodi completed diverse pharmacy experiences that strengthened her skills in patient care, medication management, interdisciplinary collaboration, and clinical decision-making. These roles helped her build a solid foundation in evidence-based medicine and therapeutic evaluation.

Originally from Bowie, MD, she earned her bachelor’s degree in biology before completing a graduate degree in biomedical sciences. This academic foundation, combined with her clinical and research training, has shaped her scientific curiosity and commitment to advancing evidence-based innovation. Dr. Oshodi looks forward to continuing her professional growth through this fellowship and contributing thoughtfully to the clinical development of emerging therapies.

St. John’s University/Otsuka America Pharmaceutical Industry Fellowship—Global Medical Affairs

Marco Ghiozzi, Pharm.D.

Marco Ghiozzi ’24Pharm.D. is the 2025–27 St. John’s University/Otsuka Pharmaceutical Industry Fellow in CNS Global Medical Strategy.

Dr. Ghiozzi earned his Doctor of Pharmacy degree from St. John’s University’s College of Pharmacy and Health Sciences. During his time at St. John’s, he was actively involved in a variety of organizations both within and beyond the pharmacy community. His leadership and engagement included the Kappa Psi Pharmaceutical Fraternity; the Student National Pharmaceutical Association; and the University’s Pep Band. Dr. Ghiozzi also completed a diverse set of rotations, including experiences in the pharmaceutical industry and multiple clinical settings that provided him a well-rounded foundation preparing him for this fellowship.

As one of the inaugural fellows in the partnership between St. John’s University and Otsuka Pharmaceutical, Dr. Ghiozzi is enthusiastic about contributing to the dynamic and collaborative culture that Otsuka fosters. He looks forward to gaining hands-on experience in Global Medical Affairs, engaging with cross-functional teams, and helping shape strategic decisions that impact patient outcomes. His goal is to contribute meaningfully to Otsuka’s mission and future initiatives.

Outside of work, Dr. Ghiozzi enjoys staying active through sports, especially basketball, and is currently training for the 2026 New York City Marathon. He values quality time with family and friends and brings a competitive spirit to game nights.

Anjali Rana, Pharm.D.

Anjali Rana ’25Pharm.D. is the 2025–27 St. John’s University/Otsuka Pharmaceutical Industry Fellow in Medical Affairs, Global Medical Strategy.

Dr. Rana earned her Doctor of Pharmacy degree from St. John’s University in Queens, NY. She gained experience across medical affairs, scientific communications, and field medical operations through an APPE rotation at Pfizer and internships at Moderna and Biolumina. Within these roles, she contributed to projects that brought scientific insights to life and strengthened collaboration across teams.

While at St. John’s, Dr. Rana presented research at national conferences and held leadership roles focused on mentorship, health equity, and patient advocacy. She aims to lead change by merging technology with medical strategy to improve patient outcomes. 

As part of the inaugural fellowship cohort, Dr. Rana is helping define the structure of this new position within Otsuka to support unified, sustainable growth across the medical team. In her free time, she enjoys hiking with her dog Fetch, discovering new restaurants around New York City, and planning her next travel adventure. She looks forward to bringing her curiosity and creativity to this chapter with Otsuka and St. John’s University.

Megan Mach, Pharm.D.

Megan Mach, Pharm.D., is the 2025–27 St. John’s/Otsuka Pharmaceutical Industry Fellow in Global Medical Strategy – Nephrology/Immunology.

Dr. Mach earned her Doctor of Pharmacy degree from UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences. Her diverse professional experience spans medical affairs, clinical pharmacology, managed care, regulatory research, drug formulation, and community pharmacy, with roles at organizations such as the US Food and Drug Administration, Pfizer, Tarsus, Catalent, and MedImpact. Through these experiences, she has contributed to early oncology drug development, regulatory policy research, medical launch strategy, and medical science communications.

Dr. Mach’s passion is to leverage her Pharm.D. degree to expand access to innovative therapies and generate evidence to support clinical practice. In addition to presenting research at national conferences, her role serving as a student ambassador reflects her commitment to leadership and outreach. She hopes to use her range of experiences to support strategic thinking within medical affairs with a patient-centered approach.

In her personal life, Dr. Mach finds joy in her friends and family, traveling, reading, weightlifting, thrifting, boba, and sunsets. She cherishes nature, with the beach being her happiest place. With her foundational training as a pharmacist and experiences across various sectors of pharma, she aspires to make meaningful contributions to the advancement of novel medications for all patients.

St. John’s University/AbbVie Pharmaceutical Industry Fellowship—Clinical Operations 

Tiasha Nandi, Pharm.D.

Tiasha Nandi, Pharm.D., is a 2026–28 St. John’s University/AbbVie Oncology Clinical Operations Fellow. 

Dr. Nandi earned her Doctor of Pharmacy degree from Ferris State University in Grand Rapids, Michigan. During pharmacy school, she was involved in research focused on antimicrobial stewardship and pharmacoepidemiology through the Collaboration to Harmonize Antimicrobial Registry Measures. Her work includes publications examining prescribing trends for medications for opioid use disorder and outpatient Clostridioides difficile treatment patterns, which she presented at Infectious Disease Week in Los Angeles, CA. 

Dr. Nandi also interned at Blue Cross Blue Shield of Michigan, where she gained experience in health outcomes, population health, and managed care. One aspect of this role she found especially meaningful was connecting directly with Medicare members through outreach focused on social determinants of health, helping identify barriers and guiding patients toward available resources. 

She remained actively involved on campus, serving as Vice President of Rho Chi and contributed to leadership initiatives within Lambda Kappa Sigma focused on professional development and mentorship. 

In her free time, Dr. Nandi enjoys staying active, traveling, coaching, and spending time with family and friends. She is an avid runner and golfer, and tutors students from middle school through college in STEM. She is excited to begin her journey in the pharmaceutical industry. She looks forward to learning from and collaborating with colleagues while growing professionally as she supports advancements in oncology, a therapeutic area in which she is passionate.

Amlan Barik, Pharm.D.

Amlan Barik, Pharm.D., M.B.A., is a 2026–28 St. John’s University/AbbVie Pharmaceutical Industry Fellow in Clinical Operations. 

Dr. Barik earned his degree from the Washington State University College of Pharmacy and Pharmaceutical Sciences. During his time in pharmacy school, he served as Worthy Chief Counselor of Phi Delta Chi; was a founding member of the Industry Pharmacists Organization; served as President of his institution’s chapter of Network for Collaborative Oncology Development and Advancement; published with the American Diabetes Association regarding advancing treatment for Type 1 Diabetes in elderly patients; and served as a formulary reviewer and monograph writer for a health-care system in the Pacific Northwest.  

Prior to pharmacy school, Dr. Barik worked as a lead chemist in regulatory programs with both the Washington State government and with the US Food and Drug Administration, focusing predominantly on the food safety program to make sure school lunches were safe for public school children throughout the United States. A strong background in regulatory insight and analytical techniques inspired him to pursue a rotation with the Managed Markets team at Novo Nordisk and to become more involved with formulary review with healthcare systems in his own state. Ultimately, personal ties to oncology, as well as an interest in advancing treatment in the field, led him to the fellowship program at St. John’s/AbbVie. 

In his free time, Dr. Barik enjoys rock climbing, playing the guitar, running, and spending time outside. He looks forward to expanding his knowledge of industry and is excited to be part of this prestigious program.

St. John's University and AbbVie Inc. Pharmaceutical Industry Fellowship

Programs Offered

Clinical Operations

Program Objective

This two-year post-doctoral pharmaceutical industry fellowship is designed to provide the Doctor of Pharmacy graduate a profound and unique experience within a pharmaceutical corporation, AbbVie Inc. The fellow will have exposure to various departments within AbbVie Inc. as well as research and teaching opportunities at St. John's University College of Pharmacy and Health Sciences. It is the goal of the program to provide the fellow with the skills and tools necessary for a successful career in the pharmaceutical industry.

The overall objective for the fellowship is to provide hands-on experience in Clinical Operations, with exposure to other functional areas during the program.

Fellowship Goals and Objectives for Clinical Operations:

• Primary Objectives:
  • Represent clinical operations on cross-functional study teams
  • Understand the operational implications across a range of studies including different Phases (1-4), study designs, indications and the full study lifecycle
  • Translate clinical study protocols into tangible operational requirements and initiate, track and deliver against these to ensure the study objectives are met
  • Confidently manage and oversee study vendors and global partners
  • Support timely data entry, cleaning, and database lock for clinical trials
  • Provide strategic and tactical input into operational plans e.g. site monitoring, risk mitigation, trial budgets, site selection, patient recruitment/retention and clinical supplies
  • Establish and drive timelines for study milestones and ensuring accurate tracking and reporting of study metrics
  • Promote and support risk-based quality management strategies
  • Engage in department and disease area-wide strategic activities to further improve study delivery

College of Pharmacy and Health Sciences Component

The fellow may apply for an affiliate faculty appointment at St. John's University College of Pharmacy and Health Sciences. Additionally, each fellow will have opportunities at the university to participate in activities to promote professional development including:

• Formal and informal educational opportunities
• Collaborative research projects with St. John's University faculty
• Development of continuing education courses
• A resident and fellow seminar series in collaboration with the College of Pharmacy and Health Sciences
• Graduate degree programs available at the university to further his or her educational development (Master's or PhD degrees)
• Teaching opportunities within the Doctor of Pharmacy Program
• Individual research project(s)
• Opportunity to participate in a Teaching Certificate Program 

Certificate of Completion

Upon successful completion of the fellowship program, a certificate of completion will be awarded by St. John’s University College of Pharmacy and Health Sciences and AbbVie Inc.

Eligibility for Fellowship

Fellows are chosen from a nationally competitive selection process. To be eligible, candidates must graduate from an Accreditation Council for Pharmacy Education (ACPE) accredited Doctor of Pharmacy program and have a keen interest in pursuing a career in the pharmaceutical industry.

Stipend and Benefits

The fellow will be a full-time St. John’s University employee. A competitive stipend will be provided as well as options for comprehensive health and dental insurance. Travel to professional meetings, conventions, and other facilities of the company may be possible.

St. John's University and Allergan Aesthetics, an AbbVie Company, Pharmaceutical Industry Fellowship

Programs Offered

Clinical Development

Program Objective

This two-year post-doctoral pharmaceutical industry fellowship is designed to provide the Doctor of Pharmacy graduate a profound and unique experience within a pharmaceutical corporation, Allergan Aesthetics, an AbbVie Company. The fellow will have exposure to various departments within Allergan Aesthetics as well as research and teaching opportunities at St. John's University College of Pharmacy and Health Sciences. It is the goal of the program to provide the fellow with the skills and tools necessary for a successful career in the pharmaceutical industry.

The overall objective for the fellowship is to provide hands-on experience in Clinical Development, with exposure to additional functional areas selected by the fellow as part of the second-year programming.

Fellowship Goals and Objectives

• Exposure to various medical and regulatory aspects of clinical development; device and/or drug development.
• Training of participants for a career in the pharmaceutical industry by allowing them “hands-on” experience.
• Provision of a hands-on experience and application to the fellow with respect to clinical study design, clinical strategy, data analysis and all aspects of clinical development.

College of Pharmacy and Health Sciences Component

The fellow may apply for an affiliate faculty appointment at St. John's University College of Pharmacy and Health Sciences. Additionally, each fellow will have opportunities at the university to participate in activities to promote professional development including:

• Formal and informal educational opportunities
• Collaborative research projects with St. John's University faculty
• Development of continuing education courses
• A resident and fellow seminar series in collaboration with the College of Pharmacy and Health Sciences 
• Graduate degree programs available at the university to further his or her educational development (Master's or PhD degrees)
• On-campus teaching opportunities within the Doctor of Pharmacy Program
• Individual research project(s)
• Opportunity to participate in a Teaching Certificate Program 

Certificate of Completion

Upon successful completion of the fellowship program, a certificate of completion will be awarded by St. John’s University College of Pharmacy and Health Sciences and Allergan Aesthetics, an AbbVie Company.

Eligibility for Fellowship

Fellows are chosen from a nationally competitive selection process. To be eligible, candidates must graduate from an Accreditation Council for Pharmacy Education (ACPE) accredited Doctor of Pharmacy program and have a keen interest in pursuing a career in the pharmaceutical industry.

Stipend and Benefits

The fellow will be a full-time St. John’s University employee. A competitive stipend will be provided as well as options for comprehensive health and dental insurance. Travel to professional meetings, conventions, and other facilities of the company may be possible.

St. John’s University and American Regent Inc. Pharmaceutical Industry Fellowship

Programs Offered

Medical Affairs

Program Objective

The two-year post-doctoral pharmaceutical industry fellowship is designed to provide the Doctor of Pharmacy graduate a profound and unique experience within a pharmaceutical corporation, American Regent. The fellow will have exposure to various departments within American Regent as well as research and teaching opportunities at St. John’s University College of Pharmacy and Health Sciences. It is the goal of the program to provide the fellow with the skills and tools necessary for a successful career in the pharmaceutical industry.

Medical Affairs

Pharmacists in the Department of Medical Affairs provide efficient and unbiased medical information concerning the company’s pharmaceutical products to healthcare professionals, consumers, and internal associates. Upon completion of rotation within this department, the fellow will be able to:

Medical Affairs Overview:

• Develop and utilize strong clinical trial analysis skills to evaluate medical literature, interpret scientific data, and support healthcare professionals and consumers 

• Create and present educational lectures on products and disease states to internal and external stakeholders 

• Attend medical/scientific meetings to ensure an in-depth understanding of the latest advances and updated scientific information that will help shape our publication and Investigator Sponsored Study strategies 

• Work with the Medical Affairs team including, but not limited to: Medical Communications Leads, Medical Science Liaisons, Medical Directors, Medical Writers, and other relevant team members on the development and approval of core clinical material 

• Manage company expectations while effectively integrating key clinical messages for dissemination to a wide array of audiences 

• Acquire the medical expertise and experience to thrive in the pharmaceutical industry while complying with FDA and PhRMA regulations 


Medical Science Liaison (MSL) Overview:

• Establish and maintain working relationships with healthcare professionals 

• Provide education by creating scientific dialogue around American Regent products and sponsored research 

• Fellows will have the opportunity to shadow the Medical Science Liaison (MSL) team and attend relevant conferences to deepen their understanding of Medical Affairs in a professional, pharmaceutical industry setting 


College of Pharmacy and Health Sciences Overview

The fellow may apply for an affiliate faculty appointment at St. John’s University College of Pharmacy and Health Sciences and will precept entry-level Doctor of Pharmacy students who are assigned to American Regent, Inc. for experiential training. Additionally, each fellow will have opportunities at the university to participate in activities to promote professional development including:

• Formal and informal educational opportunities
• Collaborative research projects with St. John’s University faculty
• Development of continuing education courses
• A resident and fellow seminar series in collaboration with the College of Pharmacy and Health Sciences
• Graduate degree programs available at the university to further his or her educational development (Master’s or PhD degrees)
• On-campus teaching opportunities within the Doctor of Pharmacy Program
• Individual research project(s)
• Opportunity to participate in a Teaching Certificate Program

Certificate of Completion

Upon successful completion of the fellowship program, a certificate of completion will be awarded by St. John’s University College of Pharmacy and Health Sciences and American Regent.

Eligibility for Fellowship

Fellows are chosen from a nationally competitive selection process. To be eligible, candidates must graduate from an Accreditation Council for Pharmacy Education (ACPE) accredited Doctor of Pharmacy program and have a keen interest in pursuing a career in the pharmaceutical industry.

Stipend and Benefits

The fellow will be a full-time St. John’s University employee. A competitive stipend will be provided as well as options for comprehensive health and dental insurance. Travel to professional meetings, conventions, and other facilities of the company may be possible.

St. John's University and Otsuka America Pharmaceutical, Inc. Pharmaceutical Industry Fellowship

Programs Offered

Global Medical Affairs

Program Objective

This two-year post-doctoral pharmaceutical industry fellowship is designed to provide the Doctor of Pharmacy graduate a profound and unique experience within a pharmaceutical corporation, Otsuka America Pharmaceutical, Inc. The fellow will have exposure to various departments within Otsuka as well as research and teaching opportunities at St. John's University College of Pharmacy and Health Sciences. It is the goal of the program to provide the fellow with the skills and tools necessary for a successful career in the pharmaceutical industry.

The overall objective for the fellowship is to provide hands-on experience in Global Medical Affairs, with exposure to other functional areas during the program.

• Primary Objectives:

  • Develop a strategic mindset within the Medical Affairs function, with a focus on US and global strategy.

  • Foster cross-functional collaboration skills by engaging with stakeholders across clinical development, regulatory, commercial, GVRWE, medical communications and other internal functions.

  • Enhance core competencies in areas of Medical Affairs tactical work including but not limited to scientific communication, data interpretation, real-world evidence integration, post launch initiatives and launch readiness.

  • Prepare fellows for future leadership roles by providing mentorship, ownership of high-impact projects, and exposure to global strategic planning processes.

• Upon program completion, fellows will be equipped to:

  • Strategically contribute to global and regional medical affairs initiatives, including strategic planning, data dissemination, and launch execution.

  • Collaborate effectively with cross-functional teams to align on global objectives and drive execution across multiple geographies and stakeholders.

  • Lead and manage projects that support organizational goals, demonstrating initiative, accountability, and communication excellence.

  • Navigate the complexities of the pharmaceutical industry with confidence, agility, and a strong understanding of the evolving healthcare landscape.

College of Pharmacy and Health Sciences Component

The fellow may apply for an affiliate faculty appointment at St. John's University College of Pharmacy and Health Sciences. Additionally, each fellow will have opportunities at the university to participate in activities to promote professional development including:

• Formal and informal educational opportunities
• Collaborative research projects with St. John's University faculty
• Development of continuing education courses
• A resident and fellow seminar series in collaboration with the College of Pharmacy and Health Sciences
• Graduate degree programs available at the university to further his or her educational development (Master's or PhD degrees)
• On-campus teaching opportunities within the Doctor of Pharmacy Program
• Individual research project(s)
• Opportunity to participate in a Teaching Certificate Program

Certificate of Completion

Upon successful completion of the fellowship program, a certificate of completion will be awarded by St. John’s University College of Pharmacy and Health Sciences and Otsuka America Pharmaceutical, Inc.

Eligibility for Fellowship

Fellows are chosen from a nationally competitive selection process. To be eligible, candidates must graduate from an Accreditation Council for Pharmacy Education (ACPE) accredited Doctor of Pharmacy program and have a keen interest in pursuing a career in the pharmaceutical industry.

Stipend and Benefits

The fellow will be a full-time St. John’s University employee. A competitive stipend will be provided as well as options for comprehensive health and dental insurance. Travel to professional meetings, conventions, and other facilities of the company may be possible.

St. John's University and Pfizer Inc. Pharmaceutical Industry Fellowship

Programs Offered

Health Economics and Outcomes Research (HEOR)/Market Access

Program Objective

The two-year post-doctoral pharmaceutical industry fellowship is designed to provide the Doctor of Pharmacy graduate a profound and unique experience within a pharmaceutical corporation, Pfizer. The fellow will have exposure to various departments within Pfizer as well as research and teaching opportunities at St. John's University College of Pharmacy and Health Sciences. It is the goal of the program to provide the fellow with the skills and tools necessary for a successful career in the pharmaceutical industry. 

The objective for the fellowship is to provide hands-on experience in advanced techniques pertaining to HEOR evaluation of cancer pharmaceuticals, in addition to market access experience, to introduce and develop valuable skills in an increasingly important discipline. During this unique two-year fellowship, the fellow will use her/his skills to make positive impact on global patient care. The fellowship spans a variety of payer archetypes and involves establishing strong working relationship with market access, HEOR, commercial, medical and clinical develop functions. 

Fellowship Goals and Objectives

• Build and maintain expertise in payer regulations and priorities across major countries
• Partner with an asset market access lead to execute the market access and pricing strategy for the assigned oncology asset, which includes but is not limited to, executing payer market research, developing payer value proposition and story, market access and pricing negotiations, payer benefit analysis, and contracting solutions
• Gain proficiency in the field of health economics, outcomes research, and comparative effectiveness research (CER)
• In collaboration with global HEOR leads, conduct outcomes research evaluations with real world data, develop health economics models to characterize and communicate product budget impact and cost-effectiveness; participate in HEOR projects and gain experience in how a pharmaceutical manufacturer uses clinical, economic and humanistic data to support the development and commercialization of its products
• Lead the timely development of United States HEOR launch excellence deliverables including economic models and innovative tools to successfully support launch reimbursement and access requirements
• Manage multiple projects and budgets to target and interact with vendors to execute projects
• Determine appropriate action, execution, tracking and monitoring of projects
• Attend professional meetings, as well as internal business meetings, with travel, attendance, and associated cost reimbursed dependent on active research dissemination and business objectives and need

College of Pharmacy and Health Sciences Component

The fellow may apply for an affiliate faculty appointment at St. John's University College of Pharmacy and Health Sciences. Additionally, each fellow will have opportunities at the university to participate in activities to promote professional development including:

• Formal and informal educational opportunities
• Collaborative research projects with St. John's University faculty
• Development of continuing education courses
• A resident and fellow seminar series in collaboration with the College of Pharmacy and Health Sciences 
• Graduate degree programs available at the university to further his or her educational development (Master's or PhD degrees)
• On-campus teaching opportunities within the Doctor of Pharmacy Program
• Individual research project(s)
• Opportunity to participate in a Teaching Certificate Program

Certificate of Completion

Upon successful completion of the fellowship program, a certificate of completion will be awarded by St. John’s University College of Pharmacy and Health Sciences and Pfizer.

Eligibility for Fellowship

Fellows are chosen from a nationally competitive selection process. To be eligible, candidates must graduate from an Accreditation Council for Pharmacy Education (ACPE) accredited Doctor of Pharmacy program and have a keen interest in pursuing a career in the pharmaceutical industry.

Stipend and Benefits

The fellow will be a full-time St. John’s University employee. A competitive stipend will be provided as well as options for comprehensive health and dental insurance. Travel to professional meetings, conventions, and other facilities of the company may be possible.

St. John's University and PTC Therapeutics Pharmaceutical Industry Fellowship

Programs Offered

Global Regulatory Affairs

Program Objective

This two-year post-doctoral pharmaceutical industry fellowship is designed to provide the Doctor of Pharmacy graduate a profound and unique experience within a pharmaceutical corporation, PTC Therapeutics. The fellow will have exposure to various departments within PTC Therapeutics as well as research and teaching opportunities at St. John's University College of Pharmacy and Health Sciences. It is the goal of the program to provide the fellow with the skills and tools necessary for a successful career in the pharmaceutical industry.

The overall objective for the fellowship is to receive hands-on experience in Global Regulatory Affairs, with exposure to other functional areas during the program.

Fellowship Goals and Objectives

• Serve as the primary liaison between PTC, CROs, and Health Authorities worldwide (e.g., the US FDA)
• Provide strategic input and tactical support to expedite development, submissions, and regulatory approvals
• Participate in the development of global regulatory strategies supporting development, approval, and maintenance of drugs and biologics
• Participate in Health Authority (HA) interactions and assess impact of HA feedback
• Submit and maintain regulatory applications including INDs, CTAs, NDA/BLAs
• Work with matrix team members (R&D and Non-R&D) to identify solutions that meet regulatory requirements as well as commercial objectives
• Provide support to the life-cycle management activities

College of Pharmacy and Health Sciences Component

The fellow may apply for an affiliate faculty appointment at St. John's University College of Pharmacy and Health Sciences. Additionally, each fellow will have opportunities at the university to participate in activities to promote professional development including:

• Formal and informal educational opportunities
• Collaborative research projects with St. John's University faculty
• Development of continuing education courses
• A resident and fellow seminar series in collaboration with the College of Pharmacy and Health Sciences 
• Graduate degree programs available at the university to further his or her educational development (Master's or PhD degrees)
• On-campus teaching opportunities within the Doctor of Pharmacy Program
• Individual research project(s)
• Opportunity to participate in a Teaching Certificate Program 

Certificate of Completion

Upon successful completion of the fellowship program, a certificate of completion will be awarded by St. John’s University College of Pharmacy and Health Sciences and PTC Therapeutics.

Eligibility for Fellowship

Fellows are chosen from a nationally competitive selection process. To be eligible, candidates must graduate from an Accreditation Council for Pharmacy Education (ACPE) accredited Doctor of Pharmacy program and have a keen interest in pursuing a career in the pharmaceutical industry.

Stipend and Benefits

The fellow will be a full-time St. John’s University employee. A competitive stipend will be provided as well as options for comprehensive health and dental insurance. Travel to professional meetings, conventions, and other facilities of the company may be possible.